147 related articles for article (PubMed ID: 37942971)
1. [The possibilities of Mexidol usage in neuropediatrics].
Zavadenko NN; Suvorinova NY; Zavadenko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9. Vyp. 2):43-50. PubMed ID: 37942971
[TBL] [Abstract][Full Text] [Related]
2. [Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)].
Zavadenko NN; Suvorinova NY; Batysheva TT; Bykova OV; Platonova AN; Gaynetdinova DD; Levitina EV; Mashin VV; Vakula IN; Maximova NE
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):75-86. PubMed ID: 35485068
[TBL] [Abstract][Full Text] [Related]
3. [Modern strategies of protection of hypoxic-ischemic brain damage].
Yanishevsky SN; Tsygan NV; Golokhvastov SY; Andreev RV; Litvinenko IV; Karpova OS; Yakovleva VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):78-86. PubMed ID: 29411750
[TBL] [Abstract][Full Text] [Related]
4. [Mexidol effect on the factor induced by hypoxia HIF-1α expression in the rat cerebral cortex in ischemia].
Yakusheva EN; Mylnikov PY; Chernykh IV; Shchulkin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):87-91. PubMed ID: 29171495
[TBL] [Abstract][Full Text] [Related]
5. [The impact of therapy with Mexidol on neurological deficit and functional outcome in patients with ischemic stroke: a systematic review and meta-analysis].
Voznyuk IA; Kolomentsev SV; Morozova EM
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):49-60. PubMed ID: 38148698
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of mexidol during perinatal encephalopathy in early age children].
Natriashvili GD; Kapanadze NB; Natriashvili SG
Georgian Med News; 2005 Jun; (123):35-9. PubMed ID: 16052053
[TBL] [Abstract][Full Text] [Related]
7. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
Zakharov VV; Vakhnina NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities of using Mexidol in the complex therapy of mental disorders].
Shamrey VK; Kurasov ES; Nechiporenko VV; Kolchev AI; Tsygan NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(5):160-164. PubMed ID: 32621483
[TBL] [Abstract][Full Text] [Related]
9. [A modern concept of antihypoxic and antioxidant effects of mexidol].
Shchulkin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12. Vyp. 2):87-93. PubMed ID: 30830123
[TBL] [Abstract][Full Text] [Related]
10. [Effect of mexidol on the course of post-traumatic epilepsy].
Novikov VE; Maslova NN
Eksp Klin Farmakol; 2003; 66(4):9-11. PubMed ID: 14558343
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke].
Chefranova ZhIu; Makotrova TA; Udachin VA; Koledintseva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):49-52. PubMed ID: 22810741
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].
Zhuravleva MV; Shchukin IA; Fidler MS; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):60-66. PubMed ID: 33449535
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
[TBL] [Abstract][Full Text] [Related]
15. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children].
Levitina EV
Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497
[TBL] [Abstract][Full Text] [Related]
16. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
Vizilo TL; Arefieva EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
[TBL] [Abstract][Full Text] [Related]
17. [Neurodevelopmental disorders in children and the possibilities of their pharmacotherapy].
Zavadenko NN; Suvorinova NY; Zavadenko AN; Fateeva VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11. Vyp. 2):38-45. PubMed ID: 35038845
[TBL] [Abstract][Full Text] [Related]
18. Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.
Frajewicki A; Laštůvka Z; Borbélyová V; Khan S; Jandová K; Janišová K; Otáhal J; Mysliveček J; Riljak V
Physiol Res; 2020 Dec; 69(Suppl 3):S379-S401. PubMed ID: 33464921
[TBL] [Abstract][Full Text] [Related]
19. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
[TBL] [Abstract][Full Text] [Related]
20. [Modern application possibilities hopanthenic acid (Pantocalcin) in treatmentdiseases of the nervous system in children].
Nemkova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):69-77. PubMed ID: 35611903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
